Search Results - "Rodman, David"

Refine Results
  1. 1
  2. 2
  3. 3

    Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function by Burton, Victoria J., Ciuclan, Loredana I., Holmes, Alan M., Rodman, David M., Walker, Christoph, Budd, David C.

    Published in Blood (06-01-2011)
    “…Mutations in bone morphogenetic protein receptor II (BMPR-II) underlie most heritable cases of pulmonary arterial hypertension (PAH). However, less than half…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle by Hagen, Moira, Fagan, Karen, Steudel, Wolfgang, Carr, Michelle, Lane, Kirk, Rodman, David M, West, James

    “…The majority of familial pulmonary arterial hypertension (PAH) cases are caused by mutations in the type 2 bone morphogenetic protein receptor (BMPR2)…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Pulmonary Hypertension in Transgenic Mice Expressing a Dominant-Negative BMPRII Gene in Smooth Muscle by West, James, Fagan, Karen, Steudel, Wolfgang, Fouty, Brian, Lane, Kirk, Harral, Julie, Hoedt-Miller, Marloes, Tada, Yuji, Ozimek, John, Tuder, Rubin, Rodman, David M

    Published in Circulation research (30-04-2004)
    “…ABSTRACT—Bone morphogenetic peptides (BMPs), a family of cytokines critical to normal development, were recently implicated in the pathogenesis of familial…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension by Guignabert, Christophe, Izikki, Mohamed, Tu, Ly Ieng, Li, Zhenlin, Zadigue, Patricia, Barlier-Mur, Anne-Marie, Hanoun, Naïma, Rodman, David, Hamon, Michel, Adnot, Serge, Eddahibi, Saadia

    Published in Circulation research (26-05-2006)
    “…One intrinsic abnormality of pulmonary artery smooth muscle cells (PA-SMCs) in human idiopathic pulmonary hypertension (iPH) is an exaggerated proliferative…”
    Get full text
    Journal Article
  10. 10

    Role of endothelin-1 in lung disease by Fagan, K A, McMurtry, I F, Rodman, D M

    Published in Respiratory research (01-01-2001)
    “…Endothelin-1 (ET-1) is a 21 amino acid peptide with diverse biological activity that has been implicated in numerous diseases. ET-1 is a potent mitogen…”
    Get full text
    Journal Article
  11. 11

    Low-Voltage-Activated (T-Type) Calcium Channels Control Proliferation of Human Pulmonary Artery Myocytes by Rodman, David M, Reese, Katherine, Harral, Julie, Fouty, Brian, Wu, Songwei, West, James, Hoedt-Miller, Marloes, Tada, Yuji, Li, Kai-Xun, Cool, Carlyne, Fagan, Karen, Cribbs, Leanne

    Published in Circulation research (29-04-2005)
    “…While Ca influx is essential for activation of the cell cycle machinery, the processes that regulate Ca influx in this context have not been fully elucidated…”
    Get full text
    Journal Article
  12. 12

    BMP signaling controls PASMC KV channel expression in vitro and in vivo by Young, Katharine A, Ivester, Charles, West, James, Carr, Michelle, Rodman, David M

    “…Bone morphogenetic proteins (BMPs) have been implicated in the pathogenesis of familial pulmonary arterial hypertension. The type 2 receptor (BMPR2) is…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice by Hocher, Berthold, Schwarz, Anja, Fagan, Karen A, Thone-Reineke, Christa, El-Hag, Karim, Kusserow, Heike, Elitok, Saban, Bauer, Christian, Neumayer, Hans-H, Rodman, David M, Theuring, Franz

    “…The pulmonary endothelin (ET) system has been implicated in the pathogenesis of chronic lung diseases such as pulmonary hypertension, asthma, chronic…”
    Get full text
    Journal Article
  15. 15

    Abstract 17143: Lorundrostat for Treatment of Obesity-Related, Aldosterone-Dependent Hypertension - An Endotype-Specific, Targeted Approach to the Treatment of Uncontrolled Hypertension by Rodman, David, Cizman, Borut

    Published in Circulation (New York, N.Y.) (07-11-2023)
    “…Abstract only Hyperaldosteronism manifests as low renin hypertension (HTN) with endothelial dysfunction and vascular fibrosis. In the aging vasculature, these…”
    Get full text
    Journal Article
  16. 16

    Effect of the S‐nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma by Que, Loretta G., Yang, Zhonghui, Lugogo, Njira L., Katial, Rohit K., Shoemaker, Steven A., Troha, Janice M., Rodman, David M., Tighe, Robert M., Kraft, Monica

    Published in Immunity, Inflammation and Disease (01-06-2018)
    “…Rationale Patients with asthma demonstrate depletion of the endogenous bronchodilator GSNO and upregulation of GSNOR. Objectives An exploratory proof of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Second-Strand Genome Conversion of Adeno-Associated Virus Type 2 (AAV-2) and AAV-5 Is Not Rate Limiting following Apical Infection of Polarized Human Airway Epithelia by Ding, Wei, Yan, Ziying, Zak, Roman, Saavedra, Milene, Rodman, David M, Engelhardt, John F

    Published in Journal of Virology (01-07-2003)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  19. 19

    Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension by Fagan, K A, Morrissey, B, Fouty, B W, Sato, K, Harral, J W, Morris, Jr, K G, Hoedt-Miller, M, Vidmar, S, McMurtry, I F, Rodman, D M

    Published in Respiratory research (04-09-2001)
    “…The importance of nitric oxide (NO) in hypoxic pulmonary hypertension has been demonstrated using nitric oxide synthase (NOS) knockout mice. In that model NO…”
    Get full text
    Journal Article
  20. 20